anti-inflammatory effects seem not to be gender-specific in animal models. 
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The authors declare that this material has not been published or is under active consideration by another journal. This research was conducted in accordance with the Guide for the Care and Valproate, an indirect γ-aminobutiric acid agonist has been successfully used in various 2 painful conditions. Despite its frequent use, limited pre-clinical and clinical data exist about its 3 analgesic effect. We tested valproate p.o. in increasing doses (10, 25, 50 , 100 mg/kg) in acute 4 nociception models in mice (writhing test and formalin licking-paw test) and in acute primary 5 thermal hyperalgesia induced by carrageenan in rats, comparing its effects to a non-treated 6 control and morphine (5 mg/kg), amitriptyline (10 mg/kg) or indomethacin (10 mg/kg).
7
Valproate showed a statiscally significant (p<0.001) dose-response effect in these models, both 8 in male and female mice and in female rats. Antihyperalgesic effect of valproate in the plantar 9 model was not reverted by reserpine pre-treatment. Interestingly, the maximum effect of 10 valproate on this model occurred at a dose of 50mg/kg and the higher dose of 100mg/kg showed 11 a minor effect. Additionally, we demonstrated that valproate has anti-inflammatory effect in the 12 carrageenan-induced oedema model in male and female mice. Valproate antinociceptive and 13 anti-inflammatory effects seem not to be gender-specific in animal models. 14 15 Introduction: 16 Valproic acid (valproate, di-n-propylacetic acid, VPA) is a short chain fatty acid that was 17 used infrequently since its synthesis in 1882 as a "metabolically inert" solvent for organic 18 compounds. In the 60s its effect as an anticonvulsant was discovered serendipitously in France. 19 Since then it has been widely used for the treatment of seizures in adults and children (Cloyd, 20 2003 (Wiffen, 2005) . However, there is an extensive 32 biological and preclinical rationale for their effect in painful diseases (Rogawski, 2004). 33 Valproate is approved in the USA for migraine treatment (Rogawski, 2004) and has been shown 34 to possess analgesic effect in acute migraine in adults and children (Freitag, 2003; Fragoso, 35 2003; Stillman, 2004; Reiter, 2005; Leniger, 2005) . It has been used for more than 20 years for 36 migraine patients and is frequently used by pain specialists for treating neuropathic pain of 37 various etiologies (Freitag, 2003; Sindrup, 2003) . Preclinical data and mechanism of action 38 knowledge about its use as analgesic are scarce and inconclusive, even though its basic 39 pharmacology indicates that it could be useful in neuropathic pain (Sindrup, 2003; Frenk, 1988; 40 Loscher, 1985; Cutrer, 1996) . Recently, some authors have issued moderate to strong 41 recommendations of using valproate to treat diabetic neuropathy and migraine (Rogawski, 2004; 42 Goodyear-Smith, 2009 ), whereas others have not cited it in their reviews (Veves, 2008) . 43 In the last years, criticism surfaced about the exclusive use of male animal models when 44 investigating painful syndromes. The prevalence of most common forms of pain is higher 45 among women than men, women report greater pain after invasive procedures, and women 46 display enhanced sensitivity to most forms of experimentally induced pain (with the exception 47 5 of ischemic pain) (Fillingim, 2009 (Hargreaves, 1988 Institutional Animal Care and Use Committee.
71
Writhing test: The writhing test was performed acording as described earlier (Fontenele, 1997) . Carrageenan-Induced Thermal Hyperalgesia. Plantar test was performed as previously 85 described (Hargreaves, 1988) . Briefly, each rat was placed in a Plexiglas cubicle with a glass (Fig. 2) . administration in carrageenan-treated animals, reaction times were 9.5 ± 3.0 (10 mg/kg), 11.4 ± 140 4.8 (25 mg/kg), 14.9 ± 4.8 (50 mg/kg) and 9.6 ± 3.3 (100 mg/kg). Valproate produced a 141 significant prolongation of reactions times at the dose of 25 mg/kg and 50 mg/kg (Fig. 3) . The 142 maximum effect of valproate was elicited with the 50 mg/kg dose while the 100 mg/kg dose 143 showed an effect with a magnitude comparable to the 10 mg/kg dose effect. We did not test any 144 further dose, because we were concerned with possible acute toxicity complicating the results.
145
Amitriptyline 10 mg/kg had a significant effect on plantar test, prolonging reaction time to 11.1 146 ± 4.7 seconds (p < 0.05 compared to control). In the same way indomethacin 10 mg/kg showed 147 an effect on plantar test, prolonging reaction time to 12.7 ± 5.9 seconds (p < 0.01 compared to 148 control). Pre-treatment with reserpine 5 mg/kg 6h before plantar test did not modify the effect of 149 valproate (Fig. 4) (Loscher, 1999) . Because of this characteristic of valproate, we preferred oral 171 dosing and not the more conventional parenteral route. Half-life of valproate in rats is 2-5h 172 (Loscher, 1999) and that prompted us to choose the amount of time between administration and 173 plantar test. anti-epileptic (Raftery, 1979; Carraz, 1967 , Barnes, 1975 (Loscher, 1985; Hitchcock, 1982; Swerdlow, 1981) . There has been no definitive progress in the 181 elucidation of the exact mechanisms of action of valproate in pain states, and it seems that 182 GABAergic theory is the only accepted paradigm, in the same fashion as with its anticonvulsant 183 action (Loscher, 1999; Balfour, 1994) . Few randomized controlled clinical trials have been 184 performed testing valproate as analgesic, most of them for migraine (Jensen, 1994) . A trial of 185 valproate in central pain secondary to spinal trauma reported no analgesic effect (Drewes, 1994) .
186
A group has published results of a double blind, randomized trial showing that valproate was 187 effective in diabetic neuropathy patients (Kochar, 2002) . However, their results were criticized 188 because of methodological issues (Sindrup, 2003) . Recently, the analgesic effect of valproate has 189 been questioned in the face of preclinical and clinical data (Otto, 2004; Munro, 2007) . 190 Munro et al have found no effect of i.p. valproate (10-100mg/kg, single dose immediately 191 before stimulus) in male rats, using formalin test (Munro, 2007) . Nevertheless, Czuczwar et al 192 reported effect of valproate in the same paradigm, but in female mice (Czuczwar, 2001) The hind paw was submerged to the tibiotarsal joint into the liquid-filled cell of the instrument.
The volume of the displacement, which is equal to the paw volume, was then read on a digital display. The oedema (µL) was defined as the difference between the paw volume before and 1, 2, 3, 4 and 24 h after the carrageenan administration and plotted. Statistical significance is depicted when present (One-way ANOVA with Tukey as post-hoc test).
* p < 0.05 ** p < 0.01 *** p < 0.001
